Filter Results:
(483)
Show Results For
- All HBS Web
(934)
- Faculty Publications (483)
Show Results For
- All HBS Web
(934)
- Faculty Publications (483)
- April 1989
- Supplement
Novel Combination of Two Drugs (C)
Herzlinger, Regina E. "Novel Combination of Two Drugs (C)." Harvard Business School Supplement 189-170, April 1989.
- April 1989 (Revised July 1992)
- Supplement
Technology Transfer: Anti-Inflammatory Drug (B)
Herzlinger, Regina E. "Technology Transfer: Anti-Inflammatory Drug (B)." Harvard Business School Supplement 189-166, April 1989. (Revised July 1992.)
- April 1989 (Revised July 1992)
- Supplement
Technology Transfer: Anti-Inflammatory Drug (C)
Herzlinger, Regina E. "Technology Transfer: Anti-Inflammatory Drug (C)." Harvard Business School Supplement 189-167, April 1989. (Revised July 1992.)
- March 1989 (Revised August 1989)
- Case
GI Wars: Tums vs. Rolaids—Positioning Over-the-Counter Drugs
Herzlinger, Regina E. "GI Wars: Tums vs. Rolaids—Positioning Over-the-Counter Drugs." Harvard Business School Case 189-118, March 1989. (Revised August 1989.)
- January 1989
- Case
Eli Lilly and Co.: The Beginning of a Journey in Manufacturing
Keywords: Pharmaceutical Industry
Wheelwright, Steven C. "Eli Lilly and Co.: The Beginning of a Journey in Manufacturing." Harvard Business School Case 689-014, January 1989.
- September 1988
- Background Note
Note on the Pharmaceutical Industry
Keywords: Pharmaceutical Industry
Herzlinger, Regina E. "Note on the Pharmaceutical Industry." Harvard Business School Background Note 189-076, September 1988.
- October 1987 (Revised November 1994)
- Case
Boston Fights Drugs (A): Designing Communications Research
Describes in detail the research mounted by five individuals with a $20,000 budget to combat drug abuse among Boston's school-going population. Using the focus group methodology they discover that most of the current anti-drug advertising is useless. They create their... View Details
Keywords: Budgets and Budgeting; Misleading and Fraudulent Advertising; Communication Intention and Meaning; Brands and Branding; Performance Evaluation; Research and Development; Segmentation; Pharmaceutical Industry; Boston
Rangan, V. Kasturi. "Boston Fights Drugs (A): Designing Communications Research." Harvard Business School Case 588-031, October 1987. (Revised November 1994.)
- September 1987 (Revised November 1991)
- Case
International Pharmaceuticals Inc.
By: W. Carl Kester and Richard P. Melnick
Keywords: Pharmaceutical Industry
Kester, W. Carl, and Richard P. Melnick. "International Pharmaceuticals Inc." Harvard Business School Case 288-011, September 1987. (Revised November 1991.)
- October 1986 (Revised August 2015)
- Case
Advanced Medical Technology Corporation
By: Thomas R. Piper and Steven Rogers
A loan officer must decide whether to lend $8 million to a rapidly growing high technology company. The company has had a series of relationships with three other banks. Reports from loan officers at these banks are mixed and raise questions as to the ease with which a... View Details
Keywords: Decision Making; Commercial Banking; Financing and Loans; Financial Condition; Technology Industry
Piper, Thomas R., and Steven Rogers. "Advanced Medical Technology Corporation." Harvard Business School Case 287-028, October 1986. (Revised August 2015.)
- December 1985 (Revised July 1992)
- Case
Pennsylvania Pharmaceuticals (A)
By: Michael Beer
Keywords: Pharmaceutical Industry
Beer, Michael. "Pennsylvania Pharmaceuticals (A)." Harvard Business School Case 486-073, December 1985. (Revised July 1992.)
- December 1985 (Revised July 1992)
- Supplement
Pennsylvania Pharmaceuticals (B)
By: Michael Beer
Beer, Michael. "Pennsylvania Pharmaceuticals (B)." Harvard Business School Supplement 486-074, December 1985. (Revised July 1992.)
- October 1982 (Revised May 1992)
- Case
Johnson & Johnson: The Tylenol Tragedy
In October 1982, Johnson & Johnson was confronted with a major crisis when seven deaths were attributed to poisoned Tylenol. The case reviews the facts as known a week after the incident occurred, and raises a wide range of questions regarding consumer behavior,... View Details
Keywords: Consumer Behavior; Corporate Social Responsibility and Impact; Competitive Strategy; Crisis Management; Health Care and Treatment; Pharmaceutical Industry
Greyser, Stephen A. "Johnson & Johnson: The Tylenol Tragedy." Harvard Business School Case 583-043, October 1982. (Revised May 1992.)
- July 1981 (Revised December 1984)
- Case
American Distilling Co. (A)
Fruhan, William E., Jr. "American Distilling Co. (A)." Harvard Business School Case 281-008, July 1981. (Revised December 1984.)
- July 1981 (Revised December 1984)
- Case
American Distilling Co. (B)
Fruhan, William E., Jr. "American Distilling Co. (B)." Harvard Business School Case 281-009, July 1981. (Revised December 1984.)
- April 1978
- Case
FTC and Listerine Antiseptic
Keywords: Business and Government Relations; Misleading and Fraudulent Advertising; Pharmaceutical Industry
Greyser, Stephen A. "FTC and Listerine Antiseptic." Harvard Business School Case 578-166, April 1978.
- October 1976 (Revised June 1980)
- Case
Dana Pharmaceutical
By: Thomas R. Piper
Keywords: Pharmaceutical Industry
Piper, Thomas R. "Dana Pharmaceutical." Harvard Business School Case 277-073, October 1976. (Revised June 1980.)
- January 1975 (Revised May 1983)
- Case
CIBA-GEIGY Corp. (B)
Keywords: Pharmaceutical Industry
Salter, Malcolm S. "CIBA-GEIGY Corp. (B)." Harvard Business School Case 375-247, January 1975. (Revised May 1983.)
- February 1974
- Case
Listerine Lozenges
Greyser, Stephen A. "Listerine Lozenges." Harvard Business School Case 574-062, February 1974.
- February 1973 (Revised June 1973)
- Case
Listerine Antiseptic (A)
Greyser, Stephen A. "Listerine Antiseptic (A)." Harvard Business School Case 573-060, February 1973. (Revised June 1973.)
- 2018
- Chapter
Are Licensing Markets Local? An Analysis of the Geography of Vertical Licensing Agreements in Bio-Pharmaceuticals
By: Juan Alcacer, John Cantwell and Michelle Gittelman
As the value chain of the pharmaceutical industry disaggregates, upstream discovery is increasingly carried out by small research-specialized firms while downstream development, testing and marketing is conducted by global pharmaceutical firms. Licensing plays an... View Details
Keywords: Geographic Location; Local Range; Rights; Research and Development; Biotechnology Industry; Biotechnology Industry
Alcacer, Juan, John Cantwell, and Michelle Gittelman. "Are Licensing Markets Local? An Analysis of the Geography of Vertical Licensing Agreements in Bio-Pharmaceuticals." In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. National Bureau of Economic Research, forthcoming.